2017-12-05
A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma
Publication
Publication
A multicenter phase I GRAN-T-MTC study
Polskie Archiwum Medycyny Wewnetrznej , Volume 128 - Issue 12
Medullary thyroid carcinoma (MTC) is one of the most challenging cancers.
Epidemiological studies have shown that during the past 30 years neither a change in stage at diagnosis nor a significant improvement in survival has been achieved.
Therefore, new diagnostic and therapeutic strategies are needed for early detection of metastases or disease recurrence and tumor growth control.
| Additional Metadata | |
|---|---|
| doi.org/10.20452/pamw.4387, hdl.handle.net/1765/113461 | |
| Polskie Archiwum Medycyny Wewnetrznej | |
| Organisation | Department of Radiology |
|
Erba, P., Mäcke, H., Mikolajczak, R., Decristoforo, C., Zaletel, K., Maina-Nock, T. (Theodosia), … Hubalewska-Dydejczyk, A. (2017). A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma. Polskie Archiwum Medycyny Wewnetrznej, 128(12). doi:10.20452/pamw.4387 |
|
